You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Larotrectinib

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Differentiated Thyroid Cancer, Pediatric Cancer, Cancer Trial (Larotrectinib monotherapy, 131I therapy)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • +3 more
  • Larotrectinib monotherapy
  • 131I therapy
  • (no location specified)
Mar 13, 2023

NTRK Gene Fusion - Positive Advanced or Recurrent Solid

Recruiting
  • Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
  • Larotrectinib (Vitrakvi, BAY2757556)
  • Multiple Locations, Japan
    Many locations
Jan 20, 2023

Called EPI VITRAKVI to Compare Treatment Results in Infantile

Completed
  • Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion
  • Infantile Fibrosarcoma
  • Larotrectinib (Vitrakvi, BAY2757556)
  • Standard of Care
  • Multiple Locations, France
    Multiple Locations
Jan 10, 2023

Called VICTORIA to Learn More About How Well Larotrectinib Works

Active, not recruiting
  • Solid Tumors Harboring NTRK Fusion
  • Larotrectinib(Vitrakvi, BAY2757556)
  • Data on other treatments
  • Whippany, New Jersey
    Bayer
Aug 22, 2022

High Grade Glioma, Diffuse Intrinsic Pontine Glioma Trial in Worldwide (Larotrectinib, Larotrectinib surgical)

Recruiting
  • High Grade Glioma
  • Diffuse Intrinsic Pontine Glioma
  • Larotrectinib
  • Larotrectinib surgical
  • Aurora, Colorado
  • +17 more
Aug 10, 2022

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Houston (Larotrectinib Sulfate)

Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Larotrectinib Sulfate
  • Houston, Texas
    M D Anderson Cancer Center
Apr 18, 2022

A Retro-/Prospective, Non-interventional, Cohort Study in Adult

Active, not recruiting
  • Solid Tumor, Adult
  • +2 more
    • Amiens, France
    • +3 more
    Jul 22, 2022

    Metastatic Colorectal Cancer Trial in Oslo (Alectinib, Cetuximab, Crizotinib)

    Recruiting
    • Metastatic Colorectal Cancer
    • Oslo, Norway
      Oslo University Hospital
    Feb 10, 2023

    Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Larotrectinib (Vitrakvi, BAY2757556))

    Recruiting
    • Solid Tumors Harboring NTRK Fusion
    • Larotrectinib (Vitrakvi, BAY2757556)
    • Los Angeles, California
    • +50 more
    Jan 29, 2023

    Solid Tumors Harboring NTRK Fusion Trial in United States (Larotrectinib (Vitrakvi, BAY2757556))

    Completed
    • Solid Tumors Harboring NTRK Fusion
    • Larotrectinib (Vitrakvi, BAY2757556)
    • Aurora, Colorado
    • +7 more
    May 11, 2021

    CNS Tumor, Infantile Fibrosarcoma, Recurrent Acute Leukemia Trial in Canada, United States (Larotrectinib Sulfate)

    Active, not recruiting
    • Central Nervous System Neoplasm
    • +4 more
    • Larotrectinib Sulfate
    • Birmingham, Alabama
    • +81 more
    Jan 24, 2023

    Soft Tissue Sarcoma Adult Trial in Lake Success, Portland, Seattle (Multiple drug microinjection, CIVO device)

    Completed
    • Soft Tissue Sarcoma Adult
    • Multiple drug microinjection
    • CIVO device
    • Lake Success, New York
    • +2 more
    Sep 22, 2021

    Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +30 more
    • Larotrectinib Sulfate
    • Birmingham, Alabama
    • +123 more
    Aug 23, 2022

    Solid Tumors Harboring NTRK Fusion Trial in Worldwide (BAY2757556 (Larotrectinib, Vitrakvi))

    Recruiting
    • Solid Tumors Harboring NTRK Fusion
    • BAY2757556 (Larotrectinib, Vitrakvi)
    • Palo Alto, California
    • +158 more
    Aug 8, 2022

    Tumors Harboring NTRK Fusion Trial (Larotrectinib (Vitrakvi, BAY2757556))

    Approved for marketing
    • Tumors Harboring NTRK Fusion
    • Larotrectinib (Vitrakvi, BAY2757556)
    • (no location specified)
    Dec 18, 2019

    Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • Birmingham, Alabama
    • +125 more
    Nov 21, 2022

    Cancer, Advanced Solid Tumor Trial in Kettering (lorlatinib, encorafenib + binimetinib, talazoparib)

    Recruiting
    • Cancer
    • Advanced Solid Tumor
    • Kettering, Ohio
      Kettering Health Network
    Oct 14, 2022

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +44 more
    • Biopsy
    • +23 more
    • Birmingham, Alabama
    • +166 more
    Feb 2, 2023

    AML, Adult, MDS Trial in Lørenskog (Standard therapy, Precision therapy)

    Recruiting
    • AML, Adult
    • MDS
    • Standard therapy
    • Precision therapy
    • Lørenskog, Norway
      Akershus Universitetssykehus
    Aug 23, 2021

    Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +49 more
    • Birmingham, Alabama
    • +1429 more
    Aug 17, 2022